We are live on ! Find out more
FC

Finepoint Capital Portfolio holdings

AUM $1.95B
1-Year Est. Return 45.61%
This Fund
S&P 500
This Quarter Est. Return
+40.23%
1 Year Est. Return
+45.61%
3 Year Est. Return
+24.83%
5 Year Est. Return
+26.66%
10 Year Est. Return
–
AUM
$317M
AUM Growth
+$116M
Cap. Flow
+$77.4M
Cap. Flow %
24.42%
Top 10 Hldgs %
71.68%
Holding
32
New
2
Increased
6
Reduced
1
Closed
5

Top Buys

Rank Stock Value
1
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$29M
2
LBRDK icon
Liberty Broadband Class C
LBRDK
+$15.5M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.09M
4
RVMD icon
Revolution Medicines
RVMD
+$4.57M
5
MORF
Morphic Holding, Inc. Common Stock
MORF
+$4.08M

Top Sells

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$12.3M
2
AAC.WS
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
+$334K
3
BTWNW
Bridgetown Holdings Limited Warrants
BTWNW
+$304K
4
CCVI.WS
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
+$86.4K
5
HPLTW
Home Plate Acquisition Corporation Warrant
HPLTW
+$1.97K

Sector Composition

Rank Sector Weight
1 Healthcare 80.12%
2 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
1
Cytokinetics
CYTK
$10.9B
$36M 11.37%
431,693
– –
SAVE
2
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
$27.9M 8.79%
+1,700,000
New +$24.5M
ACAD icon
3
Acadia Pharmaceuticals
ACAD
$4.38B
$24.1M 7.6%
769,653
+213,100
+38% +$5.09M
FOLD
4
DELISTED
Amicus Therapeutics
FOLD
$21.1M 6.67%
1,489,025
– –
ARVN icon
5
Arvinas
ARVN
$517M
$20.8M 6.55%
504,700
– –
ASND icon
6
Ascendis Pharma A/S
ASND
$17.1B
$20.6M 6.51%
163,772
– –
SWTX
7
DELISTED
SpringWorks Therapeutics
SWTX
$20.3M 6.41%
556,928
– –
HPLTW
8
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$20M 6.31%
331,416
-358,584
-52% -$1.97K
LKFT
9
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
$18.6M 5.88%
458,659
– –
RVMD icon
10
Revolution Medicines
RVMD
$39.6B
$17.7M 5.58%
617,100
+190,100
+45% +$4.57M
LBRDK icon
11
Liberty Broadband Class C
LBRDK
$4.43B
$14.9M 4.69%
+184,460
New +$15.5M
RLAY icon
12
Relay Therapeutics
RLAY
$4.34B
$14.5M 4.58%
1,317,870
+447,000
+51% +$3.77M
MORF
13
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$14.3M 4.53%
496,856
+171,500
+53% +$4.08M
SRPT icon
14
Sarepta Therapeutics
SRPT
$1.82B
$14M 4.42%
145,357
– –
TVTX icon
15
Travere Therapeutics
TVTX
$5.27B
$12.9M 4.07%
1,435,321
+539,500
+60% +$3.93M
PRTA icon
16
Prothena Corp
PRTA
$453M
$12.7M 4%
349,300
– –
SLDB icon
17
Solid Biosciences
SLDB
$858M
$5.9M 1.86%
961,251
– –
CLDI icon
18
Calidi Biotherapeutics
CLDI
$2.3M
$189K 0.06%
1,042
– –
CVIIW
19
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$71.3K 0.02%
548,000
– –
MLTX icon
20
MoonLake Immunotherapeutics
MLTX
$1.64B
$62.7K 0.02%
895,000
+563,584
+170% +$29M
CNDA.WS
21
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$53.1K 0.02%
408,333
– –
CLDI.WS
22
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$32.8K 0.01%
655,200
– –
ROSS.WS
23
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$24.6K 0.01%
439,666
– –
CDAQW
24
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$22.3K 0.01%
459,906
– –
GATEW
25
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$22.1K 0.01%
735,000
– –
1
2

Similar funds

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $1.94B AUM 25.76% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $1.94B AUM 14.31% 1-Year Est. Return

Finepoint Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Finepoint Capital held 32 positions worth $317M, up 58% from $201M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Finepoint Capital deployed $77.4M of net new capital in Q4 2023, opening 2 new positions and adding to 6 existing holdings. Its largest new stake was Liberty Broadband Class C: 184,460 shares worth $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 99% a quarter earlier, followed by Communication Services.

On the sell side, the largest reduction was Home Plate Acquisition Corporation Warrant, an estimated $1.97K trimmed.

  • Finepoint Capital's largest Q4 2023 buy was Liberty Broadband Class C: 184,460 shares worth $14.9M.
  • Finepoint Capital added most to MoonLake Immunotherapeutics in Q4 2023, an estimated $29M increase.
  • Finepoint Capital's biggest Q4 2023 reduction was Home Plate Acquisition Corporation Warrant, cutting an estimated $1.97K.
  • Finepoint Capital fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023, selling an estimated $12.3M.
  • Finepoint Capital's ten largest holdings make up 72% of its $317M portfolio in Q4 2023.
  • Finepoint Capital opened 2 new positions and closed 5 in Q4 2023.
  • Finepoint Capital's portfolio value rose 58% quarter-over-quarter to $317M.

Based on Finepoint Capital's 13F filing for Q4 2023, filed 13 Feb 2024.